Clinical Trial Update: A Phase I Study of Pazopanib in Combination With Trabectedin, Ipilimumab and Nivolumab (TraPIN) in Pediatric and Young Adult Patients With Recurrent Soft Tissue Sarcomas [Phase 1]

View source ↗

Summary

Phase I clinical trial update for a Pazopanib plus Trabectedin, Ipilimumab, and Nivolumab combination in pediatric and young adult patients with recurrent soft …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)
• Trabectedin (trabectedin)
• ipilimumab (ipilimumab)
• nivolumab (nivolumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Soft Tissue Sarcomas | Phase 1 | Status: NOT_YET_RECRUITING